A Study of Fluzoparib Given in Combination With Apatinib and Paclitaxel in Gastric Cancer Patients

NCT03026881 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Recurrent and Metastatic Gastric Cancer

Interventions

DRUG: Fluzoparib
DRUG: Apatinib
DRUG: Paclitaxel

Sponsor

Jiangsu HengRui Medicine Co., Ltd.

Collaborators

[object Object]